These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 11495294)
21. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607 [TBL] [Abstract][Full Text] [Related]
22. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura. Hedlund-Treutiger I; Henter JI; Elinder G J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466 [TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP. Colovic M; Dimitrijevic M; Sonnenburg C; Suvajdzic N; Donfrid M; Bogdanovic A Hematol J; 2003; 4(5):358-62. PubMed ID: 14502262 [TBL] [Abstract][Full Text] [Related]
24. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773 [TBL] [Abstract][Full Text] [Related]
25. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. Son DW; Jeon IS; Yang SW; Cho SH J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in the treatment of childhood immune thrombocytopenic purpura. Tarantino M Semin Hematol; 2006 Jul; 43(3 Suppl 5):S11-7; discussion S18-9. PubMed ID: 16815345 [TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [TBL] [Abstract][Full Text] [Related]
30. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Duru F; Fisgin T; Yarali N; Kara A Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587 [TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Blanchette V; Carcao M Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140 [TBL] [Abstract][Full Text] [Related]
32. The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura. Koçak U; Gürsel T; Oztürk G Blood Coagul Fibrinolysis; 2000 Mar; 11(2):121-5. PubMed ID: 10759004 [TBL] [Abstract][Full Text] [Related]
33. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Bussel JB; Kaufmann CP; Ware RE; Woloski BM Am J Hematol; 2001 May; 67(1):27-33. PubMed ID: 11279654 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of intravenous immunoglobulin (Flebogamma Apte S; Navarro-Puerto J; Damodar S; Ramanan V; John J; Kato G; Ross C; Shah C; Torres M; Fu C'; Rucker K; Pinciaro P; Barrera G; Aragonés ME; Ayguasanosa J Immunotherapy; 2019 Feb; 11(2):81-89. PubMed ID: 30499734 [TBL] [Abstract][Full Text] [Related]
35. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). O'Brien SH; Ritchey AK; Smith KJ Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura. Robak T; Salama A; Kovaleva L; Vyhovska Y; Davies SV; Mazzucconi MG; Zenker O; Kiessling P; Hematology; 2009 Aug; 14(4):227-36. PubMed ID: 19635187 [TBL] [Abstract][Full Text] [Related]
37. Rate of Rise of Platelet Count After IVIG for Pediatric Immune Thrombocytopenia. Mikhail D; Zhu J; Pradhan S; Freiberg AS J Pediatr Hematol Oncol; 2022 Apr; 44(3):e672-e676. PubMed ID: 35319506 [TBL] [Abstract][Full Text] [Related]
38. Treatment of acute idiopathic thrombocytopenic purpura with high-dose methylprednisolone and immunoglobulin. Barrios NJ; Humbert JR; McNeil J Acta Haematol; 1993; 89(1):6-9. PubMed ID: 8480491 [TBL] [Abstract][Full Text] [Related]
39. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial. Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA; Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954 [TBL] [Abstract][Full Text] [Related]
40. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura. Celik M; Bulbul A; Aydogan G; Tugcu D; Can E; Uslu S; Dursun M J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]